ClinicalTrials.gov
public full text
Public Domain
High On-treatment Platelet Reactivity Identified by Multiple Platelet Function Assay
High on-treatment platelet reactivity to adenosine diphosphate was a important reason to cause ischemic events in antiplatelet therapy. Using single testing to definite HPR may miss the "true HPR" or over estimate HPR, which may lead to randomized trials failed. It is not known whether combined multiple platelet function testing could assist to ensure"ture"HPR and improve clinical outcomes.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Inflammatory Biomarkers as Tool in Diagnosis and Management of Patients With Ischemic Stroke#866512
- Restart TICrH AP Pilot Trial#895262
- Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study#967089
- Individualized Antithrombotic Therapy for Patients With Ischemic Cerebrovascular Disease#904868
- COMT on Aspirin Platelets Effects (CAPE)#1139393
Record · ID 1442581
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive